HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arup Bhattacharya Selected Research

ErbB Receptors (EGF Receptor)

6/2022Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arup Bhattacharya Research Topics

Disease

22Neoplasms (Cancer)
06/2022 - 12/2004
5Urinary Bladder Neoplasms (Bladder Cancer)
08/2015 - 02/2010
4Hypoxia (Hypoxemia)
10/2018 - 12/2004
4Squamous Cell Carcinoma of Head and Neck
12/2011 - 12/2004
3Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 04/2006
3Carcinoma (Carcinomatosis)
02/2011 - 07/2006
2Breast Neoplasms (Breast Cancer)
01/2019 - 05/2015
2Renal Cell Carcinoma (Grawitz Tumor)
10/2018 - 02/2018
2Colonic Neoplasms (Colon Cancer)
02/2011 - 07/2009
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2010 - 07/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2006 - 12/2004
1Ischemic Stroke
01/2020
1Neoplasm Metastasis (Metastasis)
02/2018
1Alzheimer Disease (Alzheimer's Disease)
07/2016

Drug/Important Bio-Agent (IBA)

7selenomethylselenocysteine (methylselenocysteine)IBA
10/2018 - 06/2008
7Pharmaceutical PreparationsIBA
10/2018 - 12/2004
6Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2010
6Irinotecan (Camptosar)FDA LinkGeneric
12/2011 - 12/2004
5proline dipeptidase (prolidase)IBA
12/2021 - 05/2015
4SeleniumIBA
10/2018 - 01/2010
4allyl isothiocyanateIBA
11/2013 - 02/2010
42,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
11/2013 - 02/2010
3LigandsIBA
06/2022 - 05/2015
3Biomarkers (Surrogate Marker)IBA
10/2018 - 07/2016
3Antineoplastic Agents (Antineoplastics)IBA
07/2016 - 01/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013 - 12/2004
2Phosphotransferases (Kinase)IBA
06/2022 - 07/2016
2Fluorouracil (Carac)FDA LinkGeneric
06/2022 - 12/2004
2MicroRNAs (MicroRNA)IBA
10/2018 - 02/2018
2Dihydrotachysterol (AT 10)IBA
11/2013 - 02/2012
2Carbonic Anhydrase IXIBA
08/2008 - 12/2004
1ErbB Receptors (EGF Receptor)IBA
06/2022
1tyrosine receptor (receptor, tyrosine)IBA
06/2022
1Cetuximab (Erbitux)FDA Link
06/2022
1Panitumumab (Vectibix)FDA Link
06/2022
1Lysine (L-Lysine)FDA Link
12/2021
1Oncogene Proteins (Oncogene Protein)IBA
12/2021
1TenecteplaseFDA Link
01/2020
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2019
1human ERBB2 proteinIBA
01/2019
1Thymidine PhosphorylaseIBA
10/2018
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
10/2018
1Drug CombinationsIBA
10/2018
1LipidsIBA
10/2018
1Methionine (L-Methionine)FDA Link
10/2018
1AntioxidantsIBA
02/2018
1Selenomethionine (Sethotope)FDA Link
02/2018
1Transcription Factors (Transcription Factor)IBA
02/2018
1Axitinib (AG 013736)IBA
02/2018
1Therapeutic UsesIBA
02/2018
1Hypoxia-Inducible Factor 1IBA
02/2018
1Nuclear Proteins (Protein, Nuclear)IBA
02/2018
1Cell Surface ReceptorsIBA
07/2016
1Tyrosine (L-Tyrosine)FDA Link
07/2016
1IsothiocyanatesIBA
08/2015
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
05/2015
1Celecoxib (Celebrex)FDA Link
11/2013
1Dinoprostone (PGE2)FDA Link
11/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2013
1CaspasesIBA
11/2013
1Complement System Proteins (Complement)IBA
11/2013
1sulforaphaneIBA
01/2013
1N- acetyl- S- (N- allylthiocarbamoyl)cysteineIBA
02/2012
1Angiogenesis InhibitorsIBA
06/2011
1Green Fluorescent ProteinsIBA
02/2011
1PowdersIBA
12/2010
1sinigrinIBA
12/2010
1Merozoite Surface Protein 1 (MSA1)IBA
12/2010
1Cyclin B1IBA
12/2010
1Caspase 3 (Caspase-3)IBA
12/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2010
1Biological ProductsIBA
01/2010
1Cystine (L-Cystine)IBA
01/2010
1Tirapazamine (SR 4233)IBA
08/2008
1vadimezanIBA
07/2006
1Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2006
1raltitrexed (D 1694)IBA
04/2006
1pimonidazoleIBA
12/2004
1involucrinIBA
12/2004
1Differentiation AntigensIBA
12/2004

Therapy/Procedure

8Therapeutics
06/2022 - 12/2004
3Drug Therapy (Chemotherapy)
01/2010 - 12/2004
2Combination Drug Therapy (Combination Chemotherapy)
06/2011 - 12/2004
1Thrombectomy
01/2020
1Oral Administration
02/2018
1Aftercare (After-Treatment)
07/2006